Containing Or Obtained From Camellia (e.g., Tea, Including Green Or Black Tea, Etc.) Patents (Class 424/729)
  • Patent number: 11744793
    Abstract: Disclosed is the use of cosmetic compositions comprising an oak extract, a grape seed extract and a green tea extract to protect the skin, scalp, hair and external mucosa against air pollutants.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: September 5, 2023
    Assignee: GIVAUDAN ITALIA S.P.A.
    Inventors: Giada Maramaldi, Martino Meneghin, Federico Franceschi, Stefano Togni, Salvatore Malandrino
  • Patent number: 11690810
    Abstract: The present invention resides in the discovery that combined use of kuraridin (or any one of its analogs) and epicatechin gallate (ECG) can provide heightened level of antimicrobial activity, especially for the suppression of bacteria of the Staphylococcus aureus and Staphylococcal species. Compositions, kits, and methods for the combination use are disclosed.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: July 4, 2023
    Assignee: The Chinese University of Hong Kong
    Inventors: Margaret Ip, Kwok Pui Fung, Ping Chung Leung, Clara Bik San Lau, Quan Bin Han, Chung Lap Chan, Chit Tsui, Quande Wang
  • Patent number: 11486830
    Abstract: The present invention provides a method for determining a sensitivity to ultraviolet light non-invasively and immediately. A method for determining a UV sensitivity is provided involving: a step of irradiating the skin of a test subject with ultraviolet light to determine the UV sensitivity using the amount of biophotons to be detected within a specific period after the irradiation, wherein 50% or more of the specific period overlaps a period from 1 to 3 minutes after the irradiation.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: November 1, 2022
    Inventors: Yu Gabe, Shinya Kasamatsu, Osamu Osanai, Katsuya Takeda, Yoko Nakajima
  • Patent number: 11389497
    Abstract: Presently claimed invention related to a pharmaceutical composition comprising ascorbic acid caffeoylquinic acid, rosmarinic acid. and glycosyl sulfones obtained from Ocimum Sanctum and a process for isolating said composition from Ocimum Sanctum. Presently claimed invention also provides a method of treating neural crest derived tumors such as malignant neurofibroma and melanoma.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: July 19, 2022
    Assignee: Prime Bio, Inc.
    Inventors: Bal Ram Singh, Chandra K Mayanil, Tadanori Tomita, Raj Kumar
  • Patent number: 11173166
    Abstract: The present invention relates to compositions for inhibiting inflammation. The composition can comprise one or more natural products in the form of a nutraceutical or functional food. The present invention further relates to the combinatorial use of nutritional supplements and nutraceuticals for the prevention and/or treatment of sterile inflammation and conditions associated with sterile inflammation.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: November 16, 2021
    Assignee: BH Biotech Pty Ltd
    Inventor: Angus Harding
  • Patent number: 11141386
    Abstract: An eye health supplement and methods of using the eye health supplement are disclosed.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: October 12, 2021
    Assignee: QH Holdings (Oregon), Inc.
    Inventor: James Stringham
  • Patent number: 11135179
    Abstract: An eye health supplement and methods of using the eye health supplement are disclosed.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: October 5, 2021
    Assignee: QH Holdings (Oregon), Inc.
    Inventor: James Stringham
  • Patent number: 11077162
    Abstract: The present disclosure provides a natural plant preparation, including extracts of the following parts of plants: roots of Salvia miltiorrhiza Bunge, Juglans regia, Aesculus hippocastanum L. and Zingiber officinale Rosc., barks of Cinnamomum cassia Presl, seeds of Sesamum indicum, Carica papaya L., Nigella damascena L. and Punica granatum L., leaves of Centaurea cyanus L., resin of Pistacia Lentiscus, drupes of Cocos nucifera L., beans of Theobroma cacao L., dried pulp and kernels of Phoenix dactylifera L., dried pulp of Olea europaea, Ficus carica Linn., Walnut and Vaccinium Spp, cloves of Allium sativum, and petals of Rosa sp. The present disclosure further provides a method for preparing a plant preparation, including treating the above parts of plants with ethanol.
    Type: Grant
    Filed: December 12, 2020
    Date of Patent: August 3, 2021
    Inventors: Yuanda Song, Syed Ammar, Shaoqi Li, Wu Yang
  • Patent number: 10894071
    Abstract: The present application describes an ethyl acetate fraction of Melissa leaf having excellent angiogenesis and MMP inhibitory activities, and a composition comprising the same.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: January 19, 2021
    Assignee: ANGIOLAB, INC.
    Inventors: Min-Young Kim, Jong Cheon Hahm, Byung Young Park, Eun Kyu Park, Hee Suk Lee
  • Patent number: 10772922
    Abstract: Provided is a method of treating or preventing adenovirus and enterovirus infection by administering an antiviral composition that contains an Echinacea purpurea extract, a Salvia miltiorrhiza extract, or combinations thereof. The antiviral composition blocks adenoviruses and enterovirus infection through virucidal activity against adenovirus and inhibition of adenovirus and enterovirus attachment to and penetration into cells. Also provided is a method of preparing the antiviral composition.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: September 15, 2020
    Inventors: Luan-Yin Chang, Yu-Hsin Chen
  • Patent number: 10716767
    Abstract: The nutrient mixture made up of vitamin, carotenoid, micronutrient, essential trace element, and plant extract was much more effective in proactively protecting the corneal cells (human) and retinal pigment endothelial cells (rat) against damaging effects of H2O2 and glycosylated proteins (AGE-BSA) compared to its individual components. A mixture is made up of vitamin A, vitamin C, vitamin E, Lycopene, lutein, marigold flower extract, a saffron extract, pine bark extract, grape seed extract, bilberry extract, lipoic acid, L-Arginine and zinc.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: July 21, 2020
    Inventors: Aleksandra Niedzwiecki, Matthias W Rath, Anna Goc, Waldemar Sumera
  • Patent number: 10646466
    Abstract: A method for at least one of increasing the synthesis of melatonin and promoting the secretion of melatonin is provided, wherein the method comprises administering to a subject in need an effective amount of a compound of formula (I): A method for at least one of treating diseases related to neurometabolic disorder, preventing diseases related to neurometabolic disorder, regulating appetite, regulating mood, regulating vasoconstriction, regulating hemostatic function and regulating immune response is also provided, wherein the method comprises administering to a subject in need an effective amount of a compound of formula (I) as described above.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: May 12, 2020
    Assignee: TCI CO., LTD.
    Inventors: Yung-Hsiang Lin, Chin-Hsiu Yu, Yu-Hung Su, Shan-Yu Lin, Yu-Ming Chung
  • Patent number: 10632166
    Abstract: The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component a Theacea plant. The bioactive compositions are suitable for use in, inter alia, beverages, functional foods, nutriceuticals, supplements, and the like.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: April 28, 2020
    Assignee: ISP Investments LLC
    Inventors: Michael Koganov, Olga Dueva-Koganov, Artyom Duev, Xiaowen Hou
  • Patent number: 10610524
    Abstract: A composition interacts with a biological cell system that includes bioactive molecules with biomolecular surfaces, cellular components and water molecules with a specific density. The composition includes a biologically active component that is constructed to increase an activity of a biological cell system by increasing the hydration of one or more components of that cell system. The biologically active component may include a primary carbohydrate clathrate subcomponent that increases the H-bonded structure of water, and a secondary solute subcomponent. The biologically active component may include an inclusion complex that is made up of a clathrate component and a complex-forming compound. The clathrate subcomponent may include amyloses or cyclodextrins. There is also a beverage and a method that improves cellular hydration in an animal, such as a human.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: April 7, 2020
    Assignee: Eastpond Laboratories Limited
    Inventor: Lajos Szente
  • Patent number: 10479774
    Abstract: The present invention discloses a method for separating flavonoid substances in Camellia nitidissima Chi based on a magnetic nanoparticles-PAMAM nano composites, which comprises the following steps: preparing PAMAM dendrimer, then using the PAMAM dendrimer to prepare the magnetic nanoparticles-PAMAM nano composites, then adding the obtained magnetic nanoparticles-PAMAM nano composites in a Camellia nitidissima Chi extract, extracting and performing magnetic separation on the flavonoid substances in Camellia nitidissima Chi under ultrasound or microwave condition. According to the present invention, flavonoid substances with faintly acid characteristics are extracted and adsorbed in a plant concentrate such as Camellia nitidissima Chi or Hedyotis diffusa etc. based on the magnetic nanoparticles-PAMAM nano composites, in a successive step, high efficiency separation of the flavonoid substances can be realized by the technologies such as magnetic separation and microwave-assisted extraction.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: November 19, 2019
    Assignee: Shenzhen Violin Technology Co., Ltd.
    Inventor: Jinsheng Cheng
  • Patent number: 10456353
    Abstract: The invention relates to a personal care composition which provides enhanced inter-cellular tight junction in skin cells. The invention more particularly relates to use of such composition for application on skin, scalp, hair and oral cavity. The personal care composition comprises an extract of Aloe vera and a hyaluronic acid polymer having a molecular weight from 5 to 60 kDa.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: October 29, 2019
    Assignee: CONOPCO, INC.
    Inventors: Ramitha Kalathil, Amitabha Majumdar, Suman Majumder, Jagannath Taduri
  • Patent number: 10434087
    Abstract: Dietary supplement compositions directed to men and women and to the maintenance and improvement of human physiology, including weight, skin, hair, and general organ function and sexual health.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: October 8, 2019
    Inventor: Amen Dhyllon
  • Patent number: 10272107
    Abstract: The present invention provides methods for treating an inflammatory brain disease and for treating a traumatic brain injury in a human having an inflammatory component applying transdermal pharmaceutical compositions comprising chromium, magnesium, and thiamine as active ingredient compounds that act as neuroprotective iron chelators and brain glucose-uptake enhancement that are suitable for the treatment of traumatic brain injury. The invention further relates to methods of delivering the pharmaceutical compositions that target the brain and/or central nervous system certain novel iron chelators of the type described in the specification.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: April 30, 2019
    Inventor: Kenneth O. Russell
  • Patent number: 10245292
    Abstract: The present disclosure relates to a use of a dandelion extract and a Rooibos extract. The present disclosure also relates to a food composition and a pharmaceutical composition for preventing and improving climacteric, including a dandelion extract, or a dandelion and Rooibos composite extract as an active ingredient.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: April 2, 2019
    Assignee: FAMENITY CO., LTD
    Inventors: Do Hee Kim, Yoon Hwa Jeong, Ji Won Lee, Yoo Hun Noh, Ji Ae Park, Seng Ah Lee
  • Patent number: 10233206
    Abstract: The present invention belongs to the field of nutraceuticals or functional agents with immunostimulating capacity for triggering mechanisms of the innate immune response at a mucosal level. More specifically, it refers to the use of the compound D-fagomine as immunostimulating agent of the innate immune response in the mucosa and for the prevention or prophylaxis of inflammatory processes or diseases associated with an overactivation of the humoral immune response. The invention also relates to a composition comprising D-fagomine for the above referenced application.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: March 19, 2019
    Inventors: Sergio Pumarola Segura, Maria Carmen Antolin Mate, Marta Llopis Pages, Maria de los Angeles Calvo Torras
  • Patent number: 10183054
    Abstract: The present invention relates generally to a composition comprising palm fruit juice for use in a method of preventing and inhibiting vision loss due to angiogenesis related diseases. The composition of the present invention aids to decrease in CNV size using confocal microscopy, in addition to reduction in macrophage infiltration using immune staining; decrease in VEGF-A-induced angiogenesis using established cornea pocket assay, inhibition of IKB-D phosphorylation in laser treated choroidal tissues and reduction in macrophage recruitment to CNV lesions.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: January 22, 2019
    Inventors: Ravigadevi Sambanthamurthi, Yew Ai Tan, Ali Hafezi-Moghadam
  • Patent number: 10172784
    Abstract: The present invention relates to bioactive compositions comprising blends of camellia and feverfew serum fractions and/or kelp and parsley serum fractions.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: January 8, 2019
    Inventors: Olga V. Dueva-Koganov, Michael Koganov, Jeanette Richards, Tom Dawson, Mary Jane Combs
  • Patent number: 10092613
    Abstract: A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 4-caffeoylquinic acid (4-CQA) to total chlorogenic acids (tCGA) (5-CQA/tCGA) of from about 0.1 to about 0.2. More preferably, the green coffee extract comprises from about 6% to about 8% of 4-caffeoylquinic acid and has a total chlorogenic acid concentration that exceeds about 45%. A preferred method of administration consists of administering the green coffee extracts is a dosage of about 200 mg twice a day prior to meals on an empty stomach.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: October 9, 2018
    Assignee: NATUREX, S.A.
    Inventors: Alvin Ibarra, Marc Roller, Jacques Dikansky
  • Patent number: 10046004
    Abstract: The present disclosure relates to treatment of a pulmonary disease. The methods and kits provided herein facilitate relieving the symptoms resulting from the pulmonary disease (e.g., asthma, chronic obstructive pulmonary disease (COPD), etc.).
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: August 14, 2018
    Assignee: Shanghai KE Pharmaceutical Co., LTD
    Inventors: Minsheng Zhu, Jie Sun, Yang Pan
  • Patent number: 10010571
    Abstract: The present invention includes a method of activating irisin by administering to an individual in need of such treatment a composition comprising irisin-activating ingredients, thus increasing the conversion of white fat to BAT, and consequently, increasing metabolic rate and promoting weight loss. In an embodiment, the composition includes a Gynostemma pentaphyllum extract, a Polygonum cuspidatum root extract, capsaicinoids, and grains of paradise or constituents thereof. The composition may optionally comprise additional ingredients to activate the increased BAT, thus further increasing metabolic rate and furthering weight loss.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: July 3, 2018
    Assignee: Maximum Human Performance, LLC
    Inventors: Shane E. Durkee, Gabriel Wilson
  • Patent number: 9987218
    Abstract: A mud mask with real leaves is described. The mud mask is made by separating a leaf batch into a first sub-batch, a second sub-batch, and a third sub-batch. The first sub-batch is ground into a fine powder, while the second sub-batch remains as whole leaves and the third sub-batch is chopped into partially chopped leaves. The fine powder and whole leaves are added to hot water for a period of time to form a brewed tea. Thereafter, the partially chopped leaves and mud components are added to the brewed tea to form a mud solution, which is mixed to form the mud product. The mud product is packaged and allowed to marinate, which allows the leaves to begin releasing their nutrients and antioxidants into the mud formula, after which the mud mask includes atypical and unusually high levels of nutrients, antioxidants and caffeine.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: June 5, 2018
    Inventors: Shannon Beth Dellimore, Glenn Dellimore
  • Patent number: 9974823
    Abstract: The invention relates to a method for providing an awaking effect and specifically affecting post lunch dip in a subject comprising providing a subject with a composition comprising an isolate of guarana plant, and at least one of (i) isolate of ginkgo biloba plant or functional analog thereof and (ii) fruit sugars, wherein the composition does not affect the subject's heart activity. The invention further provides a method for affecting post lunch dip in a subject, comprising administering to the subject a daily dose of a composition comprising (i) an isolate of guarana plant, (ii) an isolate of ginkgo biloba plant or functional analog thereof and (iii) fruit sugars for a period of at least 7 days.
    Type: Grant
    Filed: June 13, 2013
    Date of Patent: May 22, 2018
    Assignee: INNO-BEV LTD.
    Inventor: Eli Faraggi
  • Patent number: 9956259
    Abstract: The present invention relates to a pharmaceutical composition for preventing and treating obesity which comprises the green tea (Camellia sinensis L.) seed husk extract or the fraction thereof as an active ingredient. The green tea seed husk extract exhibits a significant vasculogenesis suppressing effect and has been confirmed to be effective in reducing adipocytes and body weight, and thus the green tea seed husk extract can advantageously be used as an active ingredient in a composition for preventing and treating obesity, a health food for preventing and alleviating obesity, or a pharmaceutical composition for vasculogenesis suppression.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: May 1, 2018
    Inventor: Jong Deog Kim
  • Patent number: 9872850
    Abstract: Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: January 23, 2018
    Assignee: Amazentis SA
    Inventors: Christopher Lawrence Rinsch, William Blanco-Bose, Bernard Schneider, Charles Thomas, Carmen Sandi, Johan Auwerx, Penelope Andreux, Richardus Houtkooper, Eija Pirinen, Laurent Mouchiroud, David Genoux
  • Patent number: 9844531
    Abstract: Methods of decreasing muscle function decline and improving muscle function in a subject are provided. The methods utilize an effective amount of epigallocatechin-3-gallate (EGCg) to increase the level of muscle vascular endothelial growth factor A (VEGF), to decrease myostatin levels, or both, and thereby decrease muscle function decline or improve muscle function. The EGCg may be provided as part of a nutritional composition.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 19, 2017
    Inventors: Sean Garvey, Suzette Pereira, Neile Edens
  • Patent number: 9795647
    Abstract: This disclosure relates to novel herbal compositions comprising extracts of rosemary and oregano, and methods of using the herbal compositions to modulate inflammatory potential. One or both of the extracts may be supercritical extracts. The disclosure further relates to methods of treating inflammation, rheumatoid arthritis, osteoarthritis, or combinations thereof, using the herbal compositions.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: October 24, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Robert A. Newman, Peiying Yang, Paul Schulick
  • Patent number: 9770047
    Abstract: A composition of matter comprises a shelf stable, partially defatted supercritical CO2 fluid solvent extracted whole grain flour derived from a cracked biomass of perilla frutescens, the flour comprising minerals and 2 to 8 percent of native seed oil, 35 to 45 percent protein, and 35 to 45 percent fiber.
    Type: Grant
    Filed: June 5, 2013
    Date of Patent: September 26, 2017
    Inventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck, Uy Nguyen
  • Patent number: 9678075
    Abstract: The present invention pertains to the field of cancer prediction. Specifically, it relates to a method for predicting the risk of recurrence of bladder cancer in a subject after treatment of bladder cancer comprising the steps of determining the amount of at least one biomarker selected from the biomarkers shown in Table, and comparing the amount of said at least one biomarker with a reference amount for said at least one biomarker, whereby the risk of recurrence of bladder cancer is to be predicted. The present invention also contemplates a method for identifying a subject being in need of a further bladder cancer therapy. Encompassed are, furthermore, diagnostic devices and kits for carrying out said methods.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: June 13, 2017
    Assignees: Deutsches Krebsforschungszentrum, Institut Curie
    Inventors: Christoph Schröder, Harish Srinivasan, Jörg Hoheisel, François Radvanyi
  • Patent number: 9414587
    Abstract: A composition comprising a solubilized magnolol analog comprising at least one magnolol analog chosen from propyl magnolol, isopropyl magnolol, butyl magnolol, and isobutyl magnolol and a sorbitan ester. These solubilized analogs are useful in personal care, oral care, and home care compositions to provide anti-bacterial activity and reducing the expression of pro-inflammatory mediators. If isopropyl is selected, then the sorbitan ester is at least one of polyoxyethylene 20 sorbitan monooleate, and a proviso that if isobutyl magnolol is selected, then the sorbitan ester is poloxyethylene 20 sorbitan monooleate.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: August 16, 2016
    Assignee: Cologne-Palmolive Company
    Inventors: Regina Hourigan, Jeffrey Mastrull, Jairajh Mattai, James Masters
  • Patent number: 9345731
    Abstract: A herbal extract composition from Lythraceae and Lauraceae family plants and its usage as insulin resistance reducer, syndrome X normalization, pre-diabetes and type 2 diabetes treatments, particularly as activator in insulin signal pathway, as modulator in glucose transport system, as modulator in adiponectin secretion, and as suppressor in insulin resistance. Representative from Lythraceae family has been selected Lagerstroemia speciosa, and representative from Lauraceae family has been selected Cinnamomum burmannii. Such herbal extract composition work synergistically to strengthen pharmacological effect produced by each extract if they act alone.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: May 24, 2016
    Assignee: PT. DEXA MEDICA
    Inventors: Raymond R. Tjandrawinata, James M. Sinambela, Olivia Mayasari, Deasy Diah Dwi R. W., Melissa Puspasari
  • Patent number: 9308230
    Abstract: The invention relates to a preparation for medical purposes and more specifically to a preparation consisting of the combination of proanthocyanidins such as Pycnogenol or grape seeds and Centella asiatica and/or extracts thereof, for use in the prevention or treatment of atherosclerosis.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: April 12, 2016
    Inventors: Gianni Belcaro, Carolina Burki, Victor Ferrari
  • Patent number: 9192587
    Abstract: Zeaxanthin is ingested orally at suitable dosages that gives skin a darker tint that emulates a healthy suntan and that reduces the severity of unwanted skin discoloration or irregularities. In tests involving adults, it was found that zeaxanthin dosages of 30 to about 80 mg per day were sufficient to induce a mild but noticeable tinting, shading, or darkening of skin color, comparable to a mild suntan, a substantial increase in the person's ability to withstand elevated levels of sun or UV exposure without any subsequent pain or discomfort, and without the subsequent peeling and flaking that characterizes sunburns, and an increased ability of reddened and sunburned skin to convert into intact skin that looks browned and healthily tanned. The topical application of zeaxanthin can further enhance the darkening of the skin and reduce the severity of unwanted skin discoloration or irregularities.
    Type: Grant
    Filed: April 22, 2014
    Date of Patent: November 24, 2015
    Assignee: ZeaVision, LLC
    Inventors: Dennis L. Gierhart, Joseph A. Fox
  • Patent number: 9180156
    Abstract: The present application describes a composition for blood glucose control containing green tea extracts (GTE) with gallated catechins (GC) and macromolecule to prevent the intestinal absorption of GC.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: November 10, 2015
    Assignee: NUC ELECTRONICS CO., Ltd.
    Inventors: Dae-Kyu Song, Jinho Lee
  • Patent number: 9149056
    Abstract: A pet food composition having at least two carotenoids. The carotenoids can include a keto-carotenoid and at least one non-keto-carotenoid. The keto-carotenoid can include astaxanthin. The keto-carotenoid can include astaxanthin ester. The non-keto-carotenoid can include beta-carotene and/or lutein.
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: October 6, 2015
    Assignee: The Iams Company
    Inventor: Jin Zhang
  • Patent number: 9089504
    Abstract: The present invention provides a cosmetic composition containing one or more selected from a group consisting of green tea saponin and green tea polyphenol as active ingredients. The cosmetic composition of the invention is very safe to the skin and can greatly enhance biological mechanisms in the skin, and thus can serve as an anti-aging cosmetic composition.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: July 28, 2015
    Inventors: Hyun Seo Kang, Seung Hyun Kang, Ji Hyun Kim, Ji Seong Kim, Yong Joo Na, Byung Geun Chae, Sang Hoon Han
  • Publication number: 20150140135
    Abstract: A method for promoting weight loss and/or lowering blood glucose comprises an active material which may be cinnamon, an extract of cinnamon, or a derivative of a cinnamon extract. The active material may be utilized in combination with further active ingredients.
    Type: Application
    Filed: January 30, 2015
    Publication date: May 21, 2015
    Applicant: IN Ingredients, Inc.
    Inventors: Peter J. Miller, Timothy Romero
  • Publication number: 20150140031
    Abstract: Systems and methods of weight management and compositions or formulations useful therein are disclosed and described.
    Type: Application
    Filed: September 3, 2014
    Publication date: May 21, 2015
    Inventors: Steven M. Wood, Stephen J. Poole, Doug Burke, Mark Bartlett, Angela Mastaloudis
  • Publication number: 20150139938
    Abstract: The present invention provides methods of promoting arteriogenesis in a subject. Embodiments include methods comprising: administering an effective dose of tocotrienol to the subject; causing an increase in Tissue Inhibitor of Metalloproteinase Metallopeptidase Inhibitor 1 (TIMP1) in vessels of cerebrovascular collateral circulation in the subject; attenuating the activity of Matrix Metalloproteinase-2 (MMP2); thereby promoting arteriogenesis.
    Type: Application
    Filed: June 7, 2013
    Publication date: May 21, 2015
    Applicant: Ohio State Innovation Foundation
    Inventors: Chandan Sen, Cameron Rink, Sashwati Roy, Greg Christoforidis
  • Publication number: 20150132280
    Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 14, 2015
    Applicant: ORTHO-NUTRA, LLC
    Inventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss
  • Patent number: 9028886
    Abstract: The invention provides a deterioration inhibitor containing an amount of a product obtained by treatment of a tea extract with an oxidizing enzyme and then inactivating the enzyme. Addition of a deterioration inhibiting material according to the invention to a food or beverage or a cosmetic can inhibit deterioration of flavor and fragrance, with use in smaller amounts than conventional deterioration inhibitors. A particularly notable effect is exhibited against production of p-cresol and p-methylacetophenone which are citral-derived deterioration odor components, and therefore it is suitable for foods and beverages or cosmetics with citral-containing citrus-like flavors and fragrances.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: May 12, 2015
    Assignee: Ogawa & Co., Ltd.
    Inventors: Tsuyoshi Arima, Hideki Masuda
  • Publication number: 20150125548
    Abstract: The present invention is directed to nutritional and nutraceutical compositions which comprise novel mixtures of two or more indole-based dietary supplements such as L-tryptophan and melatonin, together with selected minerals and vitamins that stimulate tryptophan metabolism in the direction of serotonin and melatonin, and to their use in a preferred embodiment of the invention in a readily ingested beverage form, optionally combined with a range of other natural ingredients designed to improve the health and state of mind of human subjects. Alternative dosage forms, such as tablets for oral dosing, and dosage forms for buccal and sublingual administration, including thin films, are also incorporated in the present invention. Health improvements include the treatment of disorders of circadian rhythm, such as shift work disorder and jet lag, the induction of relaxation and a restful frame of mind, as well as providing restorative sleep function.
    Type: Application
    Filed: November 13, 2012
    Publication date: May 7, 2015
    Applicant: Requis Pharmaceuticals Inc.
    Inventors: Lars Jacob Stray Knutsen, Judi Lois Knutsen
  • Publication number: 20150118267
    Abstract: A method for enhancing the immune system or for treating an infectious disease, the method includes administering to a subject in need thereof an effective amount of theaflavins, analogs thereof, or prodrugs thereof, or includes administering to a subject a composition comprising a physiologically acceptable carrier and an effective amount of an extract of tea.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Inventors: Shiming Li, Xueyin Ren, Jianhong Liu
  • Patent number: 9011945
    Abstract: The present invention discloses the combined treatment of memantine (N-methyl-D-aspartate receptor antagonist) and tea polyphenol (an antioxidant and anti-inflammatory agent) is more effective (synergistic) in neuroprotection than either memantine or tea polyphenol alone in mouse excitotoxic injury. These findings provide useful information about the potential application of memantine and tea polyphenols in preventing or treating clinical excitotoxic injury such as brain trauma, brain ischemia, epilepsy, and Alzheimer's disease.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: April 21, 2015
    Assignee: National Taiwan University
    Inventors: Shoei-Yn Lin-Shiau, Jen-Kun Lin
  • Patent number: 9011944
    Abstract: A polyphenol composition derived from Camellia sinensis and contains flavonol aglycones and flavonol glycosides, in a weight ratio [(B)/(A)] of the following total contents (B) to (A) is from 0.01 to 18, wherein (A) total content of the flavonol aglycones contained in solids of the polyphenol composition after hydrolysis as measured by high-performance liquid chromatography, and (B) total content of the polyphenols contained in solids of the polyphenol composition as measured by the ferrous tartrate method.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: April 21, 2015
    Assignee: Kao Corporation
    Inventors: Susumu Ohishi, Norihiko Satake, Tomoko Konishi, Shinichiro Takashima
  • Publication number: 20150104393
    Abstract: A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.
    Type: Application
    Filed: October 13, 2014
    Publication date: April 16, 2015
    Inventor: Xi Zhao-Wilson